Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices

Increasing numbers of individuals with diabetes are adopting use of continuous glucose monitoring (CGM) in their daily self-management. Many of these individuals have advanced heart disease. Implantable cardioverter defibrillator (ICD) devices can effectively reduce arrhythmic death and all-cause mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes science and technology 2024-06, p.19322968241260038
Hauptverfasser: Lazar, Dylan, Tao, Michael, Matievich, William, Kastanos, Kevin, Dunn, Timothy C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 19322968241260038
container_title Journal of diabetes science and technology
container_volume
creator Lazar, Dylan
Tao, Michael
Matievich, William
Kastanos, Kevin
Dunn, Timothy C
description Increasing numbers of individuals with diabetes are adopting use of continuous glucose monitoring (CGM) in their daily self-management. Many of these individuals have advanced heart disease. Implantable cardioverter defibrillator (ICD) devices can effectively reduce arrhythmic death and all-cause mortality in individuals with advanced heart disease. However, the potential impact of ICD devices on CGM system accuracy and functionality has not been well studied. This evaluation assessed whether FreeStyle Libre (FL) CGM systems can coexist and function within the same patient in the presence of wireless interference devices, including current ICD devices. Interferer sources included Wi-Fi devices, Bluetooth devices, cellular mobile devices, implantable medical devices, Bluetooth Low-Energy (BLE) devices, BLE accessory devices and BLE mobile devices, and ICD-programmer interferers. Five testing methodologies were used to evaluate the accuracy and functionality of the CGM systems when exposed to ICD functions: high-energy emergency shocking, pacing modes, anti-tachycardia pacing mode (ATP), and DC Fibber mode. All acceptance criteria and testing requirements were met for the CGM and ICD system for wireless coexistence evaluation. Our findings demonstrated that coexisting ICD devices and FL CGM systems provide safe and effective wireless communications with functional and accurate transfer of data during scenarios expected in clinical use.
doi_str_mv 10.1177/19322968241260038
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11571575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3071281626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c239t-51298683fb5f78551780c7d6bf60573ffd59be89c205c20fc4688d27c95460f53</originalsourceid><addsrcrecordid>eNplUU1v1DAQtRCIlsIP4IJ85LLFH_FHTmi10FKp0EPL2XKccTFK7MV2VsqP4D83UZcKhOSRZzxv3oznIfSWknNKlfpAW85YKzVrKJOEcP0Mna5vG06Jen70V8AJelXKT0JEo5V6iU64bomSTXuKfm-dm7J1M7axxxdTdDWkaIdQZ5w8voUBXMW7FGuIU5oKvhwmlwrgrymGmnKI9_h2LhXGgrcZ8LdU8dW4t65Cj7t59Qcbq-0GwDub-5AOkCtk_Al86HIYBruwLNEhOCiv0QtvhwJvjvcZ-n7x-W73ZXN9c3m1215vHONt3QjKWi01953wSgtBlSZO9bLzkgjFve9F24FuHSNiMe8aqXXPlGtFI4kX_Ax9fOTdT90IvYNYsx3MPofR5tkkG8y_mRh-mPt0MJQKtZyV4f2RIadfE5RqxlAcLN-JsKzJcKIo01QyuUDpI9TlVEoG_9SHErPqaP7Tcal59_eATxV_hOMPqNqbUA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3071281626</pqid></control><display><type>article</type><title>Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices</title><source>Access via SAGE</source><creator>Lazar, Dylan ; Tao, Michael ; Matievich, William ; Kastanos, Kevin ; Dunn, Timothy C</creator><creatorcontrib>Lazar, Dylan ; Tao, Michael ; Matievich, William ; Kastanos, Kevin ; Dunn, Timothy C</creatorcontrib><description>Increasing numbers of individuals with diabetes are adopting use of continuous glucose monitoring (CGM) in their daily self-management. Many of these individuals have advanced heart disease. Implantable cardioverter defibrillator (ICD) devices can effectively reduce arrhythmic death and all-cause mortality in individuals with advanced heart disease. However, the potential impact of ICD devices on CGM system accuracy and functionality has not been well studied. This evaluation assessed whether FreeStyle Libre (FL) CGM systems can coexist and function within the same patient in the presence of wireless interference devices, including current ICD devices. Interferer sources included Wi-Fi devices, Bluetooth devices, cellular mobile devices, implantable medical devices, Bluetooth Low-Energy (BLE) devices, BLE accessory devices and BLE mobile devices, and ICD-programmer interferers. Five testing methodologies were used to evaluate the accuracy and functionality of the CGM systems when exposed to ICD functions: high-energy emergency shocking, pacing modes, anti-tachycardia pacing mode (ATP), and DC Fibber mode. All acceptance criteria and testing requirements were met for the CGM and ICD system for wireless coexistence evaluation. Our findings demonstrated that coexisting ICD devices and FL CGM systems provide safe and effective wireless communications with functional and accurate transfer of data during scenarios expected in clinical use.</description><identifier>ISSN: 1932-2968</identifier><identifier>EISSN: 1932-3107</identifier><identifier>DOI: 10.1177/19322968241260038</identifier><identifier>PMID: 38907649</identifier><language>eng</language><publisher>United States: SAGE Publications</publisher><subject>Technology Report</subject><ispartof>Journal of diabetes science and technology, 2024-06, p.19322968241260038</ispartof><rights>2024 Diabetes Technology Society 2024 Diabetes Technology Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c239t-51298683fb5f78551780c7d6bf60573ffd59be89c205c20fc4688d27c95460f53</cites><orcidid>0000-0002-9406-8342 ; 0009-0007-1222-1918</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38907649$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lazar, Dylan</creatorcontrib><creatorcontrib>Tao, Michael</creatorcontrib><creatorcontrib>Matievich, William</creatorcontrib><creatorcontrib>Kastanos, Kevin</creatorcontrib><creatorcontrib>Dunn, Timothy C</creatorcontrib><title>Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices</title><title>Journal of diabetes science and technology</title><addtitle>J Diabetes Sci Technol</addtitle><description>Increasing numbers of individuals with diabetes are adopting use of continuous glucose monitoring (CGM) in their daily self-management. Many of these individuals have advanced heart disease. Implantable cardioverter defibrillator (ICD) devices can effectively reduce arrhythmic death and all-cause mortality in individuals with advanced heart disease. However, the potential impact of ICD devices on CGM system accuracy and functionality has not been well studied. This evaluation assessed whether FreeStyle Libre (FL) CGM systems can coexist and function within the same patient in the presence of wireless interference devices, including current ICD devices. Interferer sources included Wi-Fi devices, Bluetooth devices, cellular mobile devices, implantable medical devices, Bluetooth Low-Energy (BLE) devices, BLE accessory devices and BLE mobile devices, and ICD-programmer interferers. Five testing methodologies were used to evaluate the accuracy and functionality of the CGM systems when exposed to ICD functions: high-energy emergency shocking, pacing modes, anti-tachycardia pacing mode (ATP), and DC Fibber mode. All acceptance criteria and testing requirements were met for the CGM and ICD system for wireless coexistence evaluation. Our findings demonstrated that coexisting ICD devices and FL CGM systems provide safe and effective wireless communications with functional and accurate transfer of data during scenarios expected in clinical use.</description><subject>Technology Report</subject><issn>1932-2968</issn><issn>1932-3107</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNplUU1v1DAQtRCIlsIP4IJ85LLFH_FHTmi10FKp0EPL2XKccTFK7MV2VsqP4D83UZcKhOSRZzxv3oznIfSWknNKlfpAW85YKzVrKJOEcP0Mna5vG06Jen70V8AJelXKT0JEo5V6iU64bomSTXuKfm-dm7J1M7axxxdTdDWkaIdQZ5w8voUBXMW7FGuIU5oKvhwmlwrgrymGmnKI9_h2LhXGgrcZ8LdU8dW4t65Cj7t59Qcbq-0GwDub-5AOkCtk_Al86HIYBruwLNEhOCiv0QtvhwJvjvcZ-n7x-W73ZXN9c3m1215vHONt3QjKWi01953wSgtBlSZO9bLzkgjFve9F24FuHSNiMe8aqXXPlGtFI4kX_Ax9fOTdT90IvYNYsx3MPofR5tkkG8y_mRh-mPt0MJQKtZyV4f2RIadfE5RqxlAcLN-JsKzJcKIo01QyuUDpI9TlVEoG_9SHErPqaP7Tcal59_eATxV_hOMPqNqbUA</recordid><startdate>20240622</startdate><enddate>20240622</enddate><creator>Lazar, Dylan</creator><creator>Tao, Michael</creator><creator>Matievich, William</creator><creator>Kastanos, Kevin</creator><creator>Dunn, Timothy C</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9406-8342</orcidid><orcidid>https://orcid.org/0009-0007-1222-1918</orcidid></search><sort><creationdate>20240622</creationdate><title>Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices</title><author>Lazar, Dylan ; Tao, Michael ; Matievich, William ; Kastanos, Kevin ; Dunn, Timothy C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c239t-51298683fb5f78551780c7d6bf60573ffd59be89c205c20fc4688d27c95460f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Technology Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lazar, Dylan</creatorcontrib><creatorcontrib>Tao, Michael</creatorcontrib><creatorcontrib>Matievich, William</creatorcontrib><creatorcontrib>Kastanos, Kevin</creatorcontrib><creatorcontrib>Dunn, Timothy C</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lazar, Dylan</au><au>Tao, Michael</au><au>Matievich, William</au><au>Kastanos, Kevin</au><au>Dunn, Timothy C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices</atitle><jtitle>Journal of diabetes science and technology</jtitle><addtitle>J Diabetes Sci Technol</addtitle><date>2024-06-22</date><risdate>2024</risdate><spage>19322968241260038</spage><pages>19322968241260038-</pages><issn>1932-2968</issn><eissn>1932-3107</eissn><abstract>Increasing numbers of individuals with diabetes are adopting use of continuous glucose monitoring (CGM) in their daily self-management. Many of these individuals have advanced heart disease. Implantable cardioverter defibrillator (ICD) devices can effectively reduce arrhythmic death and all-cause mortality in individuals with advanced heart disease. However, the potential impact of ICD devices on CGM system accuracy and functionality has not been well studied. This evaluation assessed whether FreeStyle Libre (FL) CGM systems can coexist and function within the same patient in the presence of wireless interference devices, including current ICD devices. Interferer sources included Wi-Fi devices, Bluetooth devices, cellular mobile devices, implantable medical devices, Bluetooth Low-Energy (BLE) devices, BLE accessory devices and BLE mobile devices, and ICD-programmer interferers. Five testing methodologies were used to evaluate the accuracy and functionality of the CGM systems when exposed to ICD functions: high-energy emergency shocking, pacing modes, anti-tachycardia pacing mode (ATP), and DC Fibber mode. All acceptance criteria and testing requirements were met for the CGM and ICD system for wireless coexistence evaluation. Our findings demonstrated that coexisting ICD devices and FL CGM systems provide safe and effective wireless communications with functional and accurate transfer of data during scenarios expected in clinical use.</abstract><cop>United States</cop><pub>SAGE Publications</pub><pmid>38907649</pmid><doi>10.1177/19322968241260038</doi><orcidid>https://orcid.org/0000-0002-9406-8342</orcidid><orcidid>https://orcid.org/0009-0007-1222-1918</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1932-2968
ispartof Journal of diabetes science and technology, 2024-06, p.19322968241260038
issn 1932-2968
1932-3107
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11571575
source Access via SAGE
subjects Technology Report
title Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T05%3A07%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20and%20Functionality%20of%20Select%20Continuous%20Glucose%20Monitoring%20Systems%20Are%20Not%20Impacted%20by%20Implantable%20Cardioverter%20Defibrillator%20Devices&rft.jtitle=Journal%20of%20diabetes%20science%20and%20technology&rft.au=Lazar,%20Dylan&rft.date=2024-06-22&rft.spage=19322968241260038&rft.pages=19322968241260038-&rft.issn=1932-2968&rft.eissn=1932-3107&rft_id=info:doi/10.1177/19322968241260038&rft_dat=%3Cproquest_pubme%3E3071281626%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3071281626&rft_id=info:pmid/38907649&rfr_iscdi=true